Orthodonticell, under your leadership as CEO & Co-Founder, Mark Terrill, has shown remarkable development in the field of orthodontics. The company's innovative approach in leveraging biotechnology to improve orthodontic treatment outcomes has been well-received in the market. Our patented technology, which focuses on accelerating bone remodeling, has the potential to revolutionize orthodontic treatment, reducing treatment times and improving patient comfort. Our team is dedicated to continuous research and development to further enhance our products and services. Despite the challenges posed by the competitive market and the ongoing pandemic, the company has managed to maintain financial stability and is on track to achieve our projected targets.More...